AST 18th Annual Scientific MeetingMay 15-19, 1999 · Sheraton Hotel and Towers · Chicago, IL |
NOTE:
You can search this page by using your
browser's "Find" function
(under the "Edit" menu in Netscape Navigator/Communicator and
Microsoft Internet Explorer)
11:00 #459 Alterations of T cell signaling pathways in allogeneic rat hosts rendered tolerant by oral administration of allochimeric class I MHC proteins. Young Investigator Award
M Wang, J Yu, K Akioka, Y Zhang, R Kirken, SM Stepkowski and BD Kahan, Houston, TX
11:10 #460 Antigen reactivated regula-tory T cells maintain infectious tolerance in transplant recipients. Young Investigator Award
B Reemtsen, H Kato, M Ghobrial, JA Goss, HD Volk, RW Busuttil and JW Kupiec-Weglinski, Los Angeles, CA and Berlin, Germany
11:20 #461 Independent roles for CD4+ and CD8+ T cells in initiating rejection of allogeneic hepatocytes.
D Gao, J Li, CG Orosz and GL Bumgardner, Columbus, OH
11:30 #462 Quantitative analysis of NFkB and IkB gene transcription within mouse cardiac allografts.
V Csizmadia, W Gao, R Tao, L Turka and WW Hancock, Cambridge; Boston, MA and Philadelphia, PA
R Josien, B Wong, J-M Heslan, H-L Li, J-P Soulillou, M-C Cuturi, R Steinman and Y Choi, Nantes, France and New York, NY
11:50 #464 TNP-470, an anti-angiogenesis agent, is a potent inhibitor of human CD4+ T cell proliferation.
MD Denton, C Magee, S Alexander, MH Sayegh and DM Briscoe, Boston, MA
12:00 #465 Inhibition of JAK3 tyrosine kinase by PNU 15804 blocks heart allograft rejection.
M-E Wang, R Kirken, F Behbod, SM Stepkowski and BD Kahan, Houston, TX
12:10 #466 The alloantibody response is dependent upon the classical pathway of complement activation.
JE Marsh, MC Carroll and SH Sacks, London, UK and Boston, MA
12:20 #467 The role of CD40 in vascular rejection: evidence against the involvement of alloantibody.
SM Ensminger, O Witzke, BM Spriewald, H Sorensen, PJ Morris, ML Rose, A Rahemtulla and KJ Wood, Oxford and Middlesex, UK
| Copyright ©1997-2000, AST |
Site
created by SLACK
Incorporated |